Skip to content

Clinical trials

Heart Failure trials in Chile

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Heart Failure Country / region: Chile Clear all

32 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20072
20122
20143
20173
20183
20201
20212
20222
20232
20244
20252
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Recruiting7
Not yet recruiting3
Terminated3
Unknown status2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca3
Amgen2
Boehringer Ingelheim2
Lexicon Pharmaceuticals2
Medtronic Cardiac Rhythm and Heart Failure2
Novartis Pharmaceuticals2
Pontificia Universidad Catolica de Chile2
Universidad Nacional Andres Bello2
Universidad de los Andes, Chile2
University of Chile2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Heart Failure32
Diabetes Mellitus, Type 24
Atrial Fibrillation2
Cardiovascular Diseases2
Dyspnea2
Hypertension2
Hyponatremia2
Renal Insufficiency, Chronic2
Acute Coronary Syndrome1
Acute Kidney Injury1

Trials

Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.